Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Greenberg

Showing results (151-160 of 156) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 156 results.
Oncotarget|November 2, 2017
Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditionsPeter Valent, Attilio Orazi, David P Steensma, et al.
Hemasphere|May 22, 2024
Toward a more patient-centered drug development process in clinical trials for patients with myelodysplastic syndromes/neoplasms (MDS): Practical considerations from the International Consortium for MDS (icMDS)Fabio Efficace, Rena Buckstein, Gregory A Abel, et al.
Nature Communications|July 12, 2025
Carbene formation as a mechanism for efficient intracellular uptake of cationic antimicrobial carbon acid polymersChong Hui Koh, Mallikharjuna Rao Lambu, Chongyun Tan, et al.
Leukemia|October 20, 2022
Finding consistency in classifications of myeloid neoplasms: a perspective on behalf of the International Workshop for Myelodysplastic SyndromesAmer M Zeidan, Jan Philipp Bewersdorf, Rena Buckstein, et al.
Blood Reviews|September 13, 2023
Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Consortium for MDS (icMDS)Maximilian Stahl, Jan Philipp Bewersdorf, Zhuoer Xie, et al.
Mayo Clinic Proceedings|July 28, 2015
In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer DrugsAyalew Tefferi, Hagop Kantarjian, S Vincent Rajkumar, et al.
Pageof 16

Showing results (151-160 of 156) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 156 results.
Oncotarget|November 2, 2017
Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditionsPeter Valent, Attilio Orazi, David P Steensma, et al.
Hemasphere|May 22, 2024
Toward a more patient-centered drug development process in clinical trials for patients with myelodysplastic syndromes/neoplasms (MDS): Practical considerations from the International Consortium for MDS (icMDS)Fabio Efficace, Rena Buckstein, Gregory A Abel, et al.
Nature Communications|July 12, 2025
Carbene formation as a mechanism for efficient intracellular uptake of cationic antimicrobial carbon acid polymersChong Hui Koh, Mallikharjuna Rao Lambu, Chongyun Tan, et al.
Leukemia|October 20, 2022
Finding consistency in classifications of myeloid neoplasms: a perspective on behalf of the International Workshop for Myelodysplastic SyndromesAmer M Zeidan, Jan Philipp Bewersdorf, Rena Buckstein, et al.
Blood Reviews|September 13, 2023
Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Consortium for MDS (icMDS)Maximilian Stahl, Jan Philipp Bewersdorf, Zhuoer Xie, et al.
Mayo Clinic Proceedings|July 28, 2015
In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer DrugsAyalew Tefferi, Hagop Kantarjian, S Vincent Rajkumar, et al.
Pageof 16